Document Detail


Effects of calcium antagonists in patients with coronary disease and heart failure: left ventricular function following nisoldipine measured by radionuclide ventriculography.
MedLine Citation:
PMID:  1282615     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thirty-two patients with chronic heart failure were investigated with radionuclide ventriculography at rest and during exercise. The global ejection fraction (EF), ejection rate, ejection time, and filling rate were measured. The patients were subdivided into three subgroups: patients with extremely (< 25%), moderately (25-33%), and mildly decreased EF (33-40%). All patients were investigated by thallium-201 myocardial scintigraphy and the correlation between ejection parameters and infarct size was investigated. In a random protocol 17 patients (14 men, 3 women, mean age of 54.6 years) received beta-acetyldigoxin at a dose of 0.3 mg daily over 4 weeks, 15 patients (13 men, 2 women, mean age of 58.2 years) received nisoldipine at a dose of 20 mg daily. Patients on digitalis showed a further lowering of the extremely decreased EF (-1%), but in patients with moderately decreased EF, digoxin produced a marked increase in EF of +8% (p < 0.001). In mildly decreased EF, there was no significant change (+0.3%, n.s.). Nisoldipine produced an increase in pump function (+2%) in the group with extremely decreased EF up to 9% in some individual cases. A significant increase (+5%) was achieved in moderately decreased EF, while patients with mildly decreased EF did not respond. Thus, nisoldipine may be indicated in the treatment of heart failure after repeated myocardial infarctions, in particular in patients with severely decreased ejection fraction.
Authors:
H Eichstaedt
Related Documents :
16596835 - Prognosis of patients with left ventricular diastolic pressure abnormality: a long-term...
2218895 - Assessment of cardiac function in patients who were morbidly obese.
23028585 - Increased metallothionein i/ii expression in patients with temporal lobe epilepsy.
12050605 - Comparison of echocardiographic markers of right ventricular function in determining pr...
20716985 - Durable alteration of the colonic microbiota by the administration of donor fecal flora.
20414055 - Immunohistochemical overexpression of the p53 protein and ki-67 (mib-1) antigen in pati...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  20 Suppl 5     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1992  
Date Detail:
Created Date:  1993-02-05     Completed Date:  1993-02-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S50-4     Citation Subset:  IM    
Affiliation:
Department of Cardiology and Radiology, University Hospital Rudolf Virchow, Berlin-Charlottenburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetyldigoxins / therapeutic use
Female
Heart / radionuclide imaging
Heart Failure / drug therapy*,  etiology,  physiopathology
Humans
Male
Middle Aged
Myocardial Infarction / complications*
Nisoldipine / therapeutic use*
Radionuclide Ventriculography
Ventricular Function, Left / drug effects*
Chemical
Reg. No./Substance:
0/Acetyldigoxins; 63675-72-9/Nisoldipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stunned and hibernating myocardium: possibility of intervention.
Next Document:  Effect of calcium antagonists on exercise tests.